Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Clinical trial NCT00660036 · TERMINATED
Trial details
- NCT number
- NCT00660036
- Sponsor
- University of Pittsburgh
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.